drugset / Trial / NCT03477266

Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery

NCT03477266

Phase 3 Completed 400 enrolled Benha University
RandomizedParallel-groupTriple-blindPrevention

Summary

Giving women one day before and immediately after cesarean section a mouthly dissolving mosapride tablets 2every every 8 hours for maximum of 5 days ,or getting recovered gastrointestinal functions And assess preoperative gastrointestinal functions

Timeline

Start
2018-04-01
Primary completion
2018-06-01
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mosapride Small molecule 5 mg Oral

Indications